JPRN-UMIN000014875已完成未知
DL cholesterol apheresis treatment for diabetic nephropathy with severe urinary protein: a multicenter prospective study - LICENSE study
Division of Nephrology, Kanazawa University Hospital0 个研究点目标入组 42 人开始时间: 2014年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-Dialysis patients -Post renal transplantation or nephrectomy -Past history undergoing LDL apheresis -Undergoing surgical procedure including revascularization within 6 month before enrollment -proliferating diabetic retinopathy or severe diabetic neuropathy -Peripheral artery disease (Rutherford class 5 or more) or post amputation
研究者
相似试验
已完成
不适用
Clinical utility of a small dense LDL cholesterol measurement reagent in coronary artery disease (CAD)coronary artery disease (CAD)JPRN-UMIN000027504Showa University3,625
尚未招募
不适用
Comparison of reduction in levels of a specific type of cholesterol in blood with the use of various standard doses of cholesterol-lowering drugsCTRI/2021/03/031826Kasturba Medical College Manipal Manipal Academy of Higher Education Manipal
尚未招募
不适用
To study sugar lowering and cholesterol lowering effects of T. Saroglitazar in patients with abnormal Sugar and CholesterolCTRI/2022/10/046795maulana azad medical college
招募中
Unknown
A Clinical study in patients with dyslipidemia to determine the actual status of the percentage of patients achieving the target values for the management of LDL-Cholesterol specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition)DyslipidemiaJPRN-UMIN000051501TOKYO CENTER CLINIC180
已完成
不适用
A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches.DyslipidemiaJPRN-UMIN000046687Medical Corporation Chiseikai Tokyo Center Clinic350